CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-11). The draft was written by AI, the existence of all 5 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 289 · Search date 2026-07-11 · Methodology v0.6

Blueberry concentrate,
does it really help with Improved memory and cognitive function?

30-Second Summary
C
Evidence Grade C · 58 · Safety acceptable
Only limited episodic- and language-memory signals remain; overall cognitive improvement has not been established
What the
research shows
A 2025 meta-analysis of nine RCTs and 513 participants was positive only for episodic memory, with an SMD of 0.34, and language memory, with an SMD of 0.30; processing speed, recognition, visuospatial learning, and working memory were null. A 24-week trial that randomized 67 participants and analyzed 57 was also null across cognition. Positive source trials were concentrated in industry funding or product provision and selected endpoints or time points, resulting in C with 58 points.
What the
ads claim
Marketing extends anthocyanins, antioxidant activity, and greater brain blood flow into memory, concentration, and dementia prevention. Direct trial evidence concerns selected cognitive-test changes, not dementia incidence or preserved daily function.
*

Useful facts when choosing a product

  • The 30 mL CherryActive concentrate, ThinkBlue purified tablet extract, and freeze-dried powder are distinct formulations and are not treated as one formulation.
  • Most positive findings involved selected domains or time points within cognitive-test batteries.
  • Several key trials received funding or products from US blueberry industry groups or ingredient companies.
  • Blueberry-only evidence was kept separate from grape-plus-blueberry combination extracts.
Gap Measurement · Verdict 289 · C 58
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The 2025 meta-analysis of nine RCTs and 513 participants found positive episodic memory, with an SMD of 0.34, and language memory, with an SMD of 0.30, but null processing speed, recognition, visuospatial learning, and working memory. Bowtell 2017 evaluated 30 mL of CherryActive concentrate in 26 participants and received product and partial funding support. Whyte 2018 evaluated ThinkBlue purified extract and low-dose powder in 122 participants, with positive findings limited to selected endpoints and time points. Cheatham 2023 reported a selected processing-speed signal. Guardino 2026 randomized 67 participants, analyzed 57, and found no overall cognitive benefit after 24 weeks of freeze-dried powder. The 30 mL concentrate, ThinkBlue tablet extract, and freeze-dried powder are distinct formulations and must not be pooled as though they were the same formulation.

02

Why this is classified as C (58)

The positive episodic- and language-memory findings across nine RCTs and 513 participants are recognized, but four other cognitive domains and the latest trial that randomized 67 and analyzed 57 were null. Concentration of positive source data in industry funding or product provision, selective endpoints and time points, and formulation heterogeneity support upper C with 58 points under boundary rule 2-b and parity with PQQ and sage.

Counterpoint. A possibility of adjunctive improvement in selected domains such as episodic memory and processing speed remains, but the judgment does not extend to global cognition or dementia prevention.

Rejudgment record. Reassessment (cross-check reflected) — Across nine RCTs and 513 participants, only episodic memory at SMD 0.34 and language memory at SMD 0.30 were positive; processing speed, recognition, visuospatial learning, working memory, and the 67-randomized, 57-analyzed 24-week trial were null. Industry funding and product provision, selective endpoints and time points, and formulation heterogeneity were reflected under boundary rule 2-b and parity with PQQ and sage

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Memory and processing speedCOnly episodic and language memory were meta-analytically positive; other cognitive domains were null
Global cognition and dementia preventionDConsistent improvement across entire cognitive batteries and dementia-incidence or daily-function outcomes has not been demonstrated

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
da Silva ABN et al. 2025Systematic review and meta-analysis of RCTs513Academic research teamsEpisodic, language, recognition, visuospatial, and working memory and processing speedOnly episodic memory at SMD 0.34 and language memory at SMD 0.30 were positive; processing speed, recognition, visuospatial learning, and working memory were null.Key synthesis
Bowtell JL et al. 2017Randomized placebo-controlled 12-week trial26CherryActive product provision and partial funding supportBrain perfusion, fMRI activation, and cognitive testsBrain perfusion and activation increased with 30 mL/day; 2-back working memory was borderline positive.Supportive
Whyte AR et al. 2018Randomized double-blind placebo-controlled six-month trial122Naturex ingredient-company participation and productsEpisodic memory, working memory, and executive functionThe 100 mg extract improved delayed word recognition at three months, but results were not consistent across all time points and domains.Key
Cheatham CL et al. 2023Randomized double-blind placebo-controlled six-month trial45Product and support from the US Highbush Blueberry CouncilCANTAB processing speed and event-related potentialsProcessing speed improved in the wild-blueberry group versus placebo.Key
Guardino ET et al. 2026Randomized double-blind placebo-controlled 24-week trial57Funded and supplied by the US Highbush Blueberry CouncilComputerized cognitive tests, p-tau181, and neurofilament lightNo between-group benefit appeared in cognitive tests or brain-injury biomarkers with 20 g/day.Key
§

Receipt — 5 References

All 5 cited sources were verified for existence at the original page (as of 2026-07-11).

da Silva ABN, de Oliveira GM, Gallo Ruelas M, Gadelha MSM, de Farias Santos ACF, Zamora FV. Blueberries for brainpower: A systematic review and meta-analysis with Bayesian post hoc analysis of RCTs exploring cognitive function in the elderly with prior cognitive decline. Biogerontology. 2025;26(5):171. PMID: 40856863. DOI: 10.1007/s10522-025-10308-w.
checked
Bowtell JL, Aboo-Bakkar Z, Conway ME, Adlam ALR, Fulford J. 2017. Enhanced task-related brain activation and resting perfusion in healthy older adults after chronic blueberry supplementation. Appl Physiol Nutr Metab. 42(7):773-779. PMID: 28249119. DOI: 10.1139/apnm-2016-0550.
checked
Whyte AR, Cheng N, Fromentin E, Williams CM. 2018. A Randomized, Double-Blinded, Placebo-Controlled Study to Compare the Safety and Efficacy of Low Dose Enhanced Wild Blueberry Powder and Wild Blueberry Extract (ThinkBlue) in Maintenance of Episodic and Working Memory in Older Adults. Nutrients. 10(6):660. PMID: 29882843. DOI: 10.3390/nu10060660.
checked
Cheatham CL, Canipe LG 3rd, Millsap G, et al. 2023. Six-month intervention with wild blueberries improved speed of processing in mild cognitive decline: a double-blind, placebo-controlled, randomized clinical trial. Nutr Neurosci. 26(10):1019-1033. PMID: 36066009. DOI: 10.1080/1028415X.2022.2117475.
checked
Guardino ET, Gabriel O, Mukamal KJ, Djousse L. 2026. Effects of a 24-week intervention with freeze-dried blueberries on brain health in older adults: A randomized double-blind, placebo-controlled trial. Clin Nutr ESPEN. 74:103377. PMID: 42251891. DOI: 10.1016/j.clnesp.2026.103377.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-11 · Corrections: none

Cite this verdict

Blueberry concentrate x Improved memory and cognitive function Evidence Grade C card
[Chamgap] Blueberry concentrate x Improved memory and cognitive function — Evidence Grade C·58. 5 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/cognition/blueberry-concentrate-memory-cognition/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.